Skip to main content
Pediatric Gastroenterology, Hepatology & Nutrition logoLink to Pediatric Gastroenterology, Hepatology & Nutrition
. 2022 Jan 7;25(1):41–51. doi: 10.5223/pghn.2022.25.1.41

Epidemiologic Changes in Over 10 Years of Community-Acquired Bacterial Enteritis in Children

Jae Jin Yang 1, Kunsong Lee 1,
PMCID: PMC8762604  PMID: 35087732

Abstract

Purpose

Community-acquired bacterial enteritis (CABE) is a common problem in developed countries. It is important to understand the epidemiologic changes in bacterial pathogens for prevention and treatment. Therefore, we studied the epidemiologic changes in CABE in Korean children.

Methods

A total of 197 hospitalized pediatric patients aged <19 years that presented with dysentery symptoms and showed positive polymerase chain reaction results for bacterial species in stool samples, were enrolled in this study for 10 years (June 2010 to June 2020). We classified patients in phase I (06, 2010–06, 2015) and phase II (07, 2015–06, 2020) and analyzed their epidemiologic and clinical characteristics.

Results

The most common pathogens were Campylobacter species (42.6%) and Salmonella species were the second most common pathogens (23.9%). The abundance of pathogens decreased in the following order: Clostridium difficile (9.6%), Shigella (5.6%), and Clostridium perfringens (5.6%). Escherichia coli O157:H7 was found to be the rarest pathogen (2.0%). Campylobacter species showed an increase in the infection rate from 32.1% in phase I to 49.6% in phase II (p=0.0011). Shigella species showed a decline in the infection rate in phase I from 14.1% to 0.0% in phase II (p<0.001). C. difficile and C. perfringens showed an increase in infection rate in phase II compared to phase I, but the difference was not statistically significant.

Conclusion

The infection rate of Campylobacter species in CABE has been rising more recently, reaching almost 50%. This study may help establish policies for prevention and treatment of CABE in Korean children.

Keywords: Campylobacter, Enteritis, Community acquired infection

INTRODUCTION

Diarrhea is mainly caused by viruses, bacteria, and parasites, and the prevalence of pathogens differs according to factors such as the environment and socio-economic status [1]. Infectious diarrhea can originate from food, water, or person-to-person contact [2]. Although diarrheal diseases have been declining as a cause of death in children in developed countries, it remains a major cause of mortality and morbidity in children in resource-limited countries [1]. Bacterial pathogens are a major source of foodborne diseases in many communities [2,3,4,5,6]. Foodborne diseases are a major public health issue and a source of community-acquired infections (CAIs) [5]. Information dissemination and surveillance for foodborne diseases have been performed by the World Health Organization and individual countries, such as by the Center for Disease Control and Prevention (CDC) in the United States and the Korea Disease Control and Prevention Agency (KDCA) in Korea.

Rotavirus is a major causative pathogen of acute diarrhea in children worldwide; however, bacterial pathogens appear to differ according to geographical area [7]. In particular, foodborne bacterial infections are an important public health issue for community-acquired bacterial enteritis (CABE) [5]. This issue is not confined to resource-limited countries. The diversity and transmission of foodborne pathogens are associated with climate change, and foodborne diseases can easily occur during outbreaks through hotels, cruise ships, resorts, childcare centers, and restaurants [5]. According to the CDC in the United States, the incidence of bacterial enteric infection through food in 2019 increased compared to 2016–2018 [8]. The most common pathogens were Campylobacter (19.5 cases per 100,000 population), followed by Salmonella (17.1), Shiga toxin-producing Escherichia coli (STEC, 6.3), Shigella (4.8), and Yersinia (1.4) [8]. The KDCA has also investigated foodborne diseases in Korea and found that the number of occurrences of foodborne infectious diseases has been steadily increasing since 2013, according to epidemiological investigation of infectious diseases in the Korea annual report 2018.

The variety and diversity of multiple pathogens in infectious diarrhea make diagnosis problematic. Stool culture, which is used as a conventional method for finding pathogens, requires specific media, environment, and a long time. These problems lead to a change in conventional methods of detection such as culture to molecular assays to detect pathogens. The stool polymerase chain reaction (PCR) test is the gold standard for identifying organisms causing infectious diarrhea in Korea. Multiplex PCR is especially useful for the simultaneous detection of multiple organisms, such as viruses and bacteria. The FilmAarray system developed recently, is a more useful multiplex PCR test that can detect multiple pathogens faster [9].

Even in countries with high economic status, the incidence of food-borne infectious diarrhea continues to appear without decreasing. To cope with this problem, continuous epidemiologic investigations on the source of the outbreak must be conducted. These systems allow us to control and prevent outbreaks and provide physicians with information and clues for appropriate management and antibiotics. In Korea, the KDCA has established a monitoring system for the outbreak of bacterial enteritis in each region and has published epidemiological data every year. However, epidemiological investigations based on age and date are insufficient. Therefore, we aimed to identify the epidemiologic characteristics for CABE in children, in this study.

MATERIALS AND METHODS

Subjects

Patients aged 0–18 years were included in this study. A total of 321 patients were admitted to Dankook University Hospital with dysentery symptoms, of which 197 patients showed positive results for stool PCR from June 2010 to June 2020. They had no underlying diseases, coinfection with viruses, or nosocomial infections.

Methods

1. Stool samples and DNA extraction

Stool was collected from patients with dysentery symptoms within the same day or at least 2 days after hospitalization and before using medication such as antibiotics. Samples were immediately delivered to the laboratory office and stored at 2–8°C. DNA was extracted from stool samples using the QIAamp DNA Stool Mini Kit (Qiagen, Germantown, MD, USA) within 24 hours after stool collection, and stool culture was performed using standard media for Salmonella, Shigella, Escherichia coli O157:H7, and Vibrio species.

2. PCR

Multiplex PCR tests were performed using the Seeplex® Diarrhea-B1 and B2 ACE Detection kit (Seegene, Seoul, Korea). This kit can detect ten pathogen species simultaneously, including Campylobacter species, Clostridium difficile toxin B, Aeromonas species, Clostridium perfringens, E. coli O157:H7, Salmonella species, Shigella species, Verocytotoxin-producing E. coli, Vibrio species, and Yersinia enterocolitica. Multiple Master Mix (DNA polymerase, buffer with deoxynucleoside triphosphates, stabilizer, and MgCl2) and 3 µL of nucleic acid were added to the PCR tube, and PCR was performed using a PCR machine (BioRAD, Hercules, CA, USA). The amplified products were separated according to size using a capillary electrophoresis system. We considered the PCR assay as the gold standard for the diagnosis of bacterial enteritis in this study.

3. Data analysis and statistics

The patients were classified into phases I and II. Phase I ran from June 2010 to June 2015 and Phase II ran from July 2015 to June 2020. The epidemiologic and clinical characteristics were retrospectively analyzed using IBM SPSS Statistics for Windows, Version 23.0 (IBM Co., Armonk, NY, USA). Fisher’s exact test and analysis of variance or Mann–Whitney U-test were used to compare continuous and categorical variables between the two groups. Statistical significance was considered at p<0.05.

4. IRB

This study was approved by the Institutional Review Board of Dankook University Hospital (IRB No. 2021-04-031-001).

RESULTS

The causative pathogens and the time of infection

The most common pathogen of CABE was Campylobacter species (84 cases, 42.6%) and Salmonella species are the second most common pathogen (47 cases, 23.9%). In the following order, C. difficile (19 cases, 9.6%), Shigella (11 cases, 5.6%), C. perfringens (11 cases, 5.6%), Aeromonas (11 cases, 5.6%), and E. coli O157:H7 was the rarest pathogen (4 cases, 2.0%) (Fig. 1). The month of august was the most common time for infection (28 cases, 14.2%), and 60.9% of infections occurred between June and October (Fig. 2).

Fig. 1. Causative pathogens of community-acquired bacterial enteritis for 10 years (June, 2010–June, 2020).

Fig. 1

Fig. 2. Frequency of infection by month.

Fig. 2

The difference in frequency of infectious pathogens according to phase

Bacterial pathogens induced in enteritis showed differences in frequency (Fig. 3). Campylobacter species were the most frequent pathogens in both phase I (06, 2010–06, 2015) and phase II (06, 2016–06, 2020) (Fig. 3). In particular, the phase II period showed a significant increase in Campylobacter infection from 32.1% in phase 1 to 49.6% of the total pathogens in phase II (p=0.011). Shigella species showed a decline in the infection rate in phase I from 14.1% to 0.0% in phase II (p<0.001). C. difficile and C. perfringens showed an increase in infection rate in phase II compared to phase I as 9.0% to 10.1% and 2.6% to 7.6%, respectively, but these differences were not statistically significant. The changes in the frequency of other pathogens also showed no significant difference.

Fig. 3. Difference in frequency of pathogens according to phase I (June, 2010–May, 2015) and phase II (July, 2015–June, 2020).

Fig. 3

The sources of causing bacterial enteritis

The most common cause of bacterial enteritis was unknown (83.2%) (Fig. 4). In cases with a definite causal relationship between enteritis and a source, pork was the most common source (5.6%). The next most common causes were chicken (4.1%), antibiotics (3.0%), and beef (1.0%). With chicken as a source, 6 (75.0%) out of 8 infectious cases were caused by Campylobacter enteritis.

Fig. 4. Causative sources of community-acquired bacterial enteritis.

Fig. 4

The difference of continuous variables based on bacterial species

The mean age of patients infected with Campylobacter species was the highest at 125.2±60.5 months compared to the mean age of patients infected with other bacterial species (p<0.001) ( Table 1). Patients infected with C. difficile were the youngest as 44.7±31.5. The mean white blood cell (WBC) count at initial examination of patients was 10,927.7±4,829.4/mm3, and patients infected with Yersinia species showed the highest WBC count as 15,758.0±8,858.4/mm3 (p=0.004). The mean C-reactive protein (CRP) level was 5.2±5.0 mg/dL. The mean CRP of patients infected with Shigella species was the highest at 7.0±6.3 mg/dL as compared to patients infected with other organisms (p<0.001).

Table 1. The characteristic of continuous variables based on bacterial species.

Bacterial species Age (mo)* WBC (/mm3) CRP (mg/dL)
Campylobacter 125.2±60.5 11,227.1±4,176.8 6.7±4.8
Salmonella 68.3±60.3 9,727.7±3,434.6 5.8±5.4
Clostridium difficile 44.7±31.5 13,961.6±8,537.3 1.0±1.2
Shigella 49.6±44.0 9,903.6±3,218.7 7.0±6.3
Clostridium perfringens 59.0±62.8 9,713.6±4,307.2 2.9±4.0
Aeromonas 52.8±39.2 11,321.8±3,136.8 1.3±1.5
Yersinia 95.4±29.6 15,758.0±8,858.4 5.6±3.6
Verocytotoxin producing Escherichia coli 62.2±81.6 6,504.0±3,044.9 4.2±5.2
E. coli O157:H7 97.0±55.9 8,845.0±2,607.6 1.3±1.4
Mean value 88.9±64.5 10,927.7±4,829.4 5.2±5.0

Values are presented as mean±standard deviation.

*Age was the mean value presented as months at admission and p-value<0.001. White blood cell (WBC) was the mean value at the first examination when the patient was hospitalized and p-value=0.004. C-reactive protein (CRP) was a mean value at admission and p-value<0.001.

DISCUSSION

Infectious diarrhea is a major cause of morbidity and mortality in children [10]. Bacterial pathogens causing infectious diarrhea are deeply associated with contaminated food and water and lead to CAI in children more vulnerable to gastrointestinal infection than adults [11].

The common pathogens causing foodborne bacterial enteritis in the United States are Campylobacter, Salmonella, STEC, Shigella and Salmonella are the most common causes of death due to diarrhea in all ages worldwide [11,12]. Nontyphoidal Salmonella was the most common bacterial enteritis in children from 0–19 years of age in the United States in 2015, followed by Campylobacter, Shigella, and STEC [13]. However, Campylobacter was the most common pathogen, followed by Salmonella, Shigella, and STEC in 2017 [13]. Campylobacter has been the common cause of bacterial enteritis since 2010, followed by Salmonella species, C. difficile, and Shigella species. Shigella was the third most common pathogen from 2010 to 2015, but infection cases were not identified from 2015 to 2020. However, Shigella species are still the major source of bacterial enteritis in developing countries [6]. In Korea, Shigella flexneri was a common illness during the Korean War, but since 2005, the incidence of Shigella has remained low [14].

Campylobacter is a zoonotic pathogen that is the most common cause of bacterial enteritis worldwide [15]. Campylobacter was the predominant pathogen that replaced Salmonella in Europe in 2005 [16]. These epidemiologic changes may be associated with climate change that impacts food production, supply, distribution, and consumption [5]. Kuhn et al. [15] reported that the number of Campylobacter infections significantly increased with increasing temperature and precipitation, so they estimated that Campylobacteriosis would increase by almost 200% in Nordic countries by the end of this century. It has been elucidated by statistical research that change in temperature and precipitation in the Nordic countries is increasing by an average of 4.2°C [15]. We also reported that the number of Campylobacter infections increased in phase II (July 2015–June 2020) than in phase I (June 2010–June 2015) in this study. According to data from KDCA on bacterial enteric infection, the most common pathogen from 2015 to 2017 was Salmonella, but from 2018, it was changed to Campylobacter. The high prevalence of Campylobacter infection is due to the low infective dose and an increase in the rate of consumption of chicken meat (according to data from Rural Development Administration in Korea, the annual consumption of chicken per person was 12.8 kg in 2014 to 14.8 kg in 2019) [16]. We presume that the increased intake of chicken meat, an increase in group feeding rates, and climate change may have affected the incidence rate of Campylobacter infection in Korea.

In the present study, we explored the epidemiologic changes in bacterial pathogens causing dysentery. We found that the infection rate of Shigella decreased, but that of C. difficile and C. perfringens increased compared to the previous rates. The infection rate of Shigella has been declining in the United States and Korea, but cases of multidrug resistance to antibiotics have been increasing, which is also a public health problem [8,17]. C. difficile is reclassified as “Clostridiodies difficile” and the most common cause of nosocomial infection or healthcare-associated infectious diarrhea [18]. However, asymptomatic carriage and CAI from food, livestock, and other environmental factors has increased to approximately 35% [18]. The CAI of C. difficile is mostly caused by the use of antibiotics and proton pump inhibitors (PPIs) and tends to prevail at a younger age than nosocomial or health care-associated infections [18]. Hafiz et al. [19] conducted a meta-analysis on the risk of community-acquired enteric infections in PPI therapy. They reported that PPI users showed an increased risk of developing community-acquired enteric infections compared to non-users, and Salmonella and Campylobacter especially had a stronger association than other bacterial pathogens on the increase of community-acquired enteric infections [19]. Son et al. [20] reported that the rate of C. difficile infection has steadily increased from 2006 to 2015 in Korea. A study on C. difficile infection in Korean children also showed an increase in the infection rate, and CAI cases showed a higher rate of abdominal pain and hematochezia than those with nosocomial infection [21]. Although there was no statistically significant difference in this study, there was an increase in the rate of C. difficile CAIs over the year. These changes in the epidemiology of C. difficile may have been caused by the increased use of antibiotics and PPIs in Korean children.

C. perfringens form spores, which allows them to be ubiquitous and can produce a large amount of toxins that cause disease in humans and animals [22]. This organism is one of the five pathogens causing foodborne illness in the United States, and one of the causes of bacterial infection outbreaks [22]. Salmonella, Campylobacter, and C. perfringens are the main bacteria that consume contaminated chicken [22]. The consumption of chicken meat is increasing worldwide [22], and it is expected that the infection rate of C. perfringens will gradually increase worldwide. In Korea, the incidence of C. perfringens infection has increased gradually since 2015.

Along with an increase in Campylobacter infections, several population-based studies have been linked to the onset of inflammatory bowel disease (IBD), which has recently increased worldwide [23]. Although the incidence or prevalence of IBD is skyrocketing worldwide as well as in Korea, it is impossible to determine the clear cause of IBD. Chronic inflammation in IBD is well known for excessive mucosal immune responses within the intestinal microflora [24]. Campylobacter infection was associated with post-infectious irritable bowel syndrome (IBS), evidenced by an event in Canada in May 2000 [24]. In this case, water contaminated with E. coli O157:H7 and Campylobacter species from livestock was supplied to people, after which more than 2,300 people showed acute enteritis and 36% of them subsequently developed post-infectious IBS [24]. There IBD and post-infectious IBS are linked with the loss of the intestinal epithelial barrier and failure to downregulate inflammation, leading to intestinal epithelial injury [24]. It was hypothesized that Campylobacter infection induced IBD by first disrupting the intestinal epithelial thigh junctions and increasing the paracellular permeability of commensal microorganisms such as E. coli, thus allowing them to translocate across the intestinal epithelium [24]. Those with an aberrant genetic background, such as a loss of function of NOD2 protein, show defects in bacterial detection and elimination, and an excessive inflammatory response via nuclear factor-κB [24]. However, Nielsen et al. [23] showed that there was no definite correlation between exposure to Campylobacter jejuni or Campylobacter concisus infection and the development of IBD in a population-based cohort study. A hypothesis about the relationship between the increase in Campylobacter infection and the rapidly increasing incidence of pediatric IBD might be possible in Korea, but further study is needed to explain this relationship. Although we did not follow up with all the patients with Campylobacter infection, there were no patients that developed IBD after Campylobacter-induced colitis, among the included patients in this study.

C. jejuni among Campylobacter species is the most common pathogenic species in human infections [25]. Cases of campylobacteriosis are very closely related to the consumption of food or drinks such as poultry, water, and contaminated unpasteurized milk [15]. The infection rate was highest in the late spring and summer seasons [15]. A study on adult patients reported that there were two peak incidences of Campylobacter infection as in younger adults (16–25 years) and older patients than 75 years [26]. In our study showed the mean age of patients with Campylobacter infection was 125.2±60.5 months (range: 0–208 months). This was the highest mean age compared to other pathogens leading to CABE.

The most common symptoms of Campylobacter infection include colicky abdominal pain, acute diarrhea, and fever [27]. In this study, fever and diarrhea were the most common symptoms seen in 92.9% of patients and 54.8% of patients showed severe diarrhea symptoms that persisted even during sleep. Jang et al. [27] reported that diarrhea was the most common symptom (97.6%), followed by fever (96.7%) and abdominal pain (94.3%) in a single-center study of Campylobacter enteritis. Laboratory findings of Campylobacter infection in CRP was 6.70±4.8 mg/dL in this study. This was the second highest level observed after Shigella infection.

In this study, elevated levels of CRP have been seen in school-age children or adolescents with fever, or abdominal pain since 2015. Based upon these findings, Campylobacter should be investigated as the primary causative pathogen, before considering other pathogens. Patients with suspected bacterial enteritis with dysenteric symptoms such as diarrhea, cholera infection with severe dehydration, premature infants, and immunocompromised children should consider empirical antibiotics [28]. Most Campylobacter enteritis cases are self-limiting, but in severe cases showing prolonged fever with severe abdominal pain or high level of CRP with persistent bloody diarrhea and immune deficiency, or in case of infected infants, appropriate empirical antibiotics should be administered early on [28]. Third-generation cephalosporins are the drug of choice for Salmonella typhi and Shigella infections [29]. Ceftriaxone was prescribed to hospitalized patients, and cefixime was used in outpatient cases with these infections [30]. However, Shigella and Salmonella species are resistant to third-generation cephalosporins, and if the patient did not show clinical improvement, azithromycin was replaced as the second antibiotic. Macrolides are the most commonly used antibiotics for Campylobacter infections that require antibiotic treatment [31]. Specifically macrolides and fluoroquinolones are the most commonly used antibiotics for Campylobacter-induced enteritis [31]. Macrolides are preferable to fluoroquinolones in children because of their low resistance rate and safety in an environment of high antibiotic resistance for enteric bacteria [31]. Among macrolides, azithromycin is the first choice for Campylobacter infection and can also be used for Vibrio cholerae, Aeromonas, Yersinia, and Shigella infections [31]. We also used ceftriaxone as the first-line treatment for CABE in our center. Therefore, we could consider azithromycin instead of ceftriaxone as the first empirical antibiotic in Korean children with indications for antibiotic use due to CABE.

This study had several limitations. First, it was a single-center study, so we cannot generalize these results as a general situation in Korean children. Second, epidemiologic data from this study cannot be reflected in the data of all Korean children because some pathogens that could not be identified in the PCR kit used in this study were excluded from the results. Third, the possibility of false-positive results for pathogens cannot be completely excluded because we did not perform culture studies for pathogens. However, despite these limitations, this study has the value of rare research on CABE in children only. We believe that this study will be helpful in recognizing the epidemiological changes in CABE in Korean children and establishing treatment policies, such as empirical antibiotics, through this study.

We should also make efforts to identify the pathogens of CABE outbreaks based on the results obtained from continuous large-scale epidemiological studies and to establish health and medical policies to decrease CABE in Korea.

Footnotes

Conflict of Interest: The authors have no financial conflicts of interest.

References

  • 1.Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther Adv Infect Dis. 2018;5:29–43. doi: 10.1177/2049936117744429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hawash YA, Ismail KA, Almehmadi M. High frequency of enteric protozoan, viral, and bacterial potential pathogens in community-acquired acute diarrheal episodes: evidence based on results of Luminex Gastrointestinal Pathogen Panel assay. Korean J Parasitol. 2017;55:513–521. doi: 10.3347/kjp.2017.55.5.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Faour-Klingbeil D, C D Todd E. Prevention and control of foodborne diseases in Middle-East North African countries: review of national control systems. Int J Environ Res Public Health. 2019;17:70. doi: 10.3390/ijerph17010070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pedersen SK, Wagenaar JA, Vigre H, Roer L, Mikoleit M, Aidara-Kane A, et al. Proficiency of WHO Global Foodborne Infections Network External Quality Assurance System participants in identification and susceptibility testing of thermotolerant Campylobacter spp. from 2003 to 2012. J Clin Microbiol. 2018;56:e01066–e01018. doi: 10.1128/JCM.01066-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lake IR, Barker GC. Climate change, foodborne pathogens and illness in higher-income countries. Curr Environ Health Rep. 2018;5:187–196. doi: 10.1007/s40572-018-0189-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sire JM, Garin B, Chartier L, Fall NK, Tall A, Seck A, et al. Community-acquired infectious diarrhoea in children under 5 years of age in Dakar, Senegal. Paediatr Int Child Health. 2013;33:139–144. doi: 10.1179/2046905512Y.0000000046. [DOI] [PubMed] [Google Scholar]
  • 7.Tian L, Zhu X, Chen Z, Liu W, Li S, Yu W, et al. Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study. BMC Infect Dis. 2016;16:253. doi: 10.1186/s12879-016-1603-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tack DM, Ray L, Griffin PM, Cieslak PR, Dunn J, Rissman T, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2016-2019. MMWR Morb Mortal Wkly Rep. 2020;69:509–514. doi: 10.15585/mmwr.mm6917a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kutsuna S, Hayakawa K, Mezaki K, Yamamoto K, Ohmagari N. Spectrum of enteropathogens in cases of traveler’s diarrhea that were detected using the FilmArray GI panel: new epidemiology in Japan. J Infect Chemother. 2021;27:49–54. doi: 10.1016/j.jiac.2020.08.009. [DOI] [PubMed] [Google Scholar]
  • 10.Wang M, Qazi IH, Wang L, Zhou G, Han H. Salmonella virulence and immune escape. Microorganisms. 2020;8:407. doi: 10.3390/microorganisms8030407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Beier RC, Foley SL, Harvey RB. Editorial for the special issue: foodborne pathogen distribution, ecology, inactivation, and methods of differentiation. Microorganisms. 2019;7:701. doi: 10.3390/microorganisms7120701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Abdoli A, Maspi N. Commentary: estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Front Med (Lausanne) 2018;5:11. doi: 10.3389/fmed.2018.00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Marder Mph EP, Griffin PM, Cieslak PR, Dunn J, Hurd S, Jervis R, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018;67:324–328. doi: 10.15585/mmwr.mm6711a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pai H. History and epidemiology of bacillary dysentery in Korea: from Korean War to 2017. Infect Chemother. 2020;52:123–131. doi: 10.3947/ic.2020.52.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kuhn KG, Nygård KM, Guzman-Herrador B, Sunde LS, Rimhanen-Finne R, Trönnberg L, et al. Campylobacter infections expected to increase due to climate change in Northern Europe. Sci Rep. 2020;10:13874. doi: 10.1038/s41598-020-70593-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schmutz C, Mäusezahl D, Jost M, Baumgartner A, Mäusezahl-Feuz M. Inverse trends of Campylobacter and Salmonella in Swiss surveillance data, 1988-2013. Euro Surveill. 2016;21:30130. doi: 10.2807/1560-7917.ES.2016.21.6.30130. [DOI] [PubMed] [Google Scholar]
  • 17.Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents. 2012;40:9–17. doi: 10.1016/j.ijantimicag.2012.02.005. [DOI] [PubMed] [Google Scholar]
  • 18.De Roo AC, Regenbogen SE. Clostridium difficile infection: an epidemiology update. Clin Colon Rectal Surg. 2020;33:49–57. doi: 10.1055/s-0040-1701229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hafiz RA, Wong C, Paynter S, David M, Peeters G. The risk of community-acquired enteric infection in proton pump inhibitor therapy: systematic review and meta-analysis. Ann Pharmacother. 2018;52:613–622. doi: 10.1177/1060028018760569. [DOI] [PubMed] [Google Scholar]
  • 20.Son KJ, Kim YA, Park YS. The trend of Clostridioides difficile infection in Korean hospitals with the analysis of nationwide sample cohort. Ann Clin Microbiol. 2020;23:241–249. [Google Scholar]
  • 21.Jeong H, Kang JM, Ahn JG. Incidence and characteristics of Clostridioides difficile infection in children. Pediatr Infect Vaccine. 2020;27:158–170. [Google Scholar]
  • 22.Mora ZV, Macías-Rodríguez ME, Arratia-Quijada J, Gonzalez-Torres YS, Nuño K, Villarruel-López A. Clostridium perfringens as foodborne pathogen in broiler production: pathophysiology and potential strategies for controlling necrotic enteritis. Animals (Basel) 2020;10:1718. doi: 10.3390/ani10091718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nielsen HL, Dalager-Pedersen M, Nielsen H. Risk of inflammatory bowel disease after Campylobacter jejuni and Campylobacter concisus infection: a population-based cohort study. Scand J Gastroenterol. 2019;54:265–272. doi: 10.1080/00365521.2019.1578406. [DOI] [PubMed] [Google Scholar]
  • 24.Kalischuk LD, Buret AG. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol. 2010;298:G1–G9. doi: 10.1152/ajpgi.00193.2009. [DOI] [PubMed] [Google Scholar]
  • 25.Bronowski C, James CE, Winstanley C. Role of environmental survival in transmission of Campylobacter jejuni. FEMS Microbiol Lett. 2014;356:8–19. doi: 10.1111/1574-6968.12488. [DOI] [PubMed] [Google Scholar]
  • 26.Trompette M, Le Guilloux L, Souply L, Denis B, Tsouria A, Garrec H, et al. Increased incidence of Campylobacter enteritis and their quinolone resistance between 2010 and 2015: results of a French national observatory conducted in 21 general hospitals (CHG) Clin Res Hepatol Gastroenterol. 2019;43:338–345. doi: 10.1016/j.clinre.2018.10.015. [DOI] [PubMed] [Google Scholar]
  • 27.Jang WT, Jo NH, Song MO, Eun BW, Ahn YM. Campylobacter enteritis: clinical features and laboratory findings in children treated at a single hospital. Pediatr Infect Vaccine. 2019;26:22–31. [Google Scholar]
  • 28.Chen J, Wan CM, Gong ST, Fang F, Sun M, Qian Y, et al. Chinese clinical practice guidelines for acute infectious diarrhea in children. World J Pediatr. 2018;14:429–436. doi: 10.1007/s12519-018-0190-2. [DOI] [PubMed] [Google Scholar]
  • 29.Dahiya S, Malik R, Sharma P, Sashi A, Lodha R, Kabra SK, et al. Current antibiotic use in the treatment of enteric fever in children. Indian J Med Res. 2019;149:263–269. doi: 10.4103/ijmr.IJMR_199_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Peretz A, Tkhawkho L, Pastukh N, Brodsky D, Halevi CN, Nitzan O. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection. BMC Infect Dis. 2016;16:309. doi: 10.1186/s12879-016-1618-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Casanovas-Moreno-Torres I, Gutiérrez-Soto B, Modovan TD, Expósito-Ruiz M, Navarro-Marí JM, Gutiérrez-Fernández J. Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter. New Microbiol. 2020;43:198–200. [PubMed] [Google Scholar]

Articles from Pediatric Gastroenterology, Hepatology & Nutrition are provided here courtesy of Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition

RESOURCES